A multi-centre study whose leads include London-based researchers has found a new imaging solution that can more effectively ...

Otherwise, because osteoporosis is typically asymptomatic, men (and women, who are also undertested and undertreated) don’t ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...

Dr. Wallen: When the prostate cancer is only in the prostate and hasn't spread elsewhere, the standard of care treatments are ...

There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

Scan.com offers fast, accessible private scans including MRI, CT and ultrasound, with results in days and no GP referral ...

New findings from the EMBARK trial reveal enzalutamide significantly reduces mortality risk in high-risk prostate cancer ...